failed trials

Karyopharm
Pharma

Karyopharm reports Xpovio miss, FDA filing in separate cancers

Reporting a new miss in one cancer indication, Karyopharm is plowing ahead with plans to advance its XPO1 inhibitor Xpovio in another.
Fraiser Kansteiner Jul 31, 2026 10:00am
Belen Garijo Sanofi Merck KGaA
Favicon Fierce Biotech

Sanofi CEO ‘looking deeply’ at pipeline as clearout continues

Jul 30, 2026 3:27am
arrow miss target fail attempt try

BMS details Krazati confirmatory fail in colorectal cancer

Jul 7, 2026 10:46am
Brinsupri

Insmed terminates development of Brinsupri in another indication

Apr 8, 2026 7:57am
layoffs cuts workforce reduction chairs boxes fired
Favicon Fierce Biotech

Biopharma layoffs maintain slowdown in Q1

Apr 1, 2026 8:42am
Brinsupri

Insmed's Brinsupri comes up short in rhinosinusitis trial

Dec 18, 2025 11:27am